This program is not sponsored or programmed by the AAAAI.

Sponsored by Circassia.

The American Thoracic Society (ATS) has developed guidelines that strongly recommend the use of FeNO as a biomarker for monitoring airway inflammation in asthma patients. At this session, learn how you can reduce asthma exacerbations by utilizing FeNO measurements obtained with the NIOX VERO® device as a biomarker in Asthma Management. An expert will review case studies of how FeNO measurements help inform assessment and treatment of asthma patients. Live performance of the NIOX VERO® will be demonstrated at this session.